ctrl K

AcelRx Pharmaceuticals In... (ACRX)

NASDAQ: ACRX · Real-Time Price · USD

0.86

0.06 (7.50%)

At close: Jan 09, 2024, 9:00 PM

AcelRx Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	651K	1.77M	2.82M	5.42M	2.29M	2.15M	8M	17.36M
Cost of Revenue	n/a	2.59M	3.75M	6.03M	6.81M	3.98M	10.66M	12.31M
Gross Profit	651K	-820K	-935K	-616K	-4.52M	-1.82M	-2.66M	5.04M
Operating Income	-16.89M	-36.63M	-35.97M	-40.96M	-54.2M	-35.73M	-38.68M	-31.96M
Interest Income	6.74M	1.5M	3.16M	3.89M	2.17M	1.14M	510K	918K
Pretax Income	-10.29M	47.77M	-35.09M	-40.38M	-53.24M	-47.15M	-52.21M	-43.19M
Net Income	-10.29M	47.76M	-35.1M	-40.38M	-53.24M	-47.15M	-51.51M	-43.16M
Selling & General & Admin	11.99M	25.67M	30.93M	36.33M	45.03M	20.77M	16.61M	15.6M
Research & Development	5.55M	5.19M	4.09M	4.02M	4.66M	13.14M	19.41M	21.4M
Other Expenses	n/a	84.05M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	17.54M	30.86M	35.03M	40.35M	49.69M	33.9M	36.02M	37M
Interest Expense	134K	1.15M	2.29M	3.31M	1.2M	12.56M	14.04M	12.15M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	1.1M	n/a	n/a	n/a
Cost & Expenses	17.54M	33.46M	38.78M	46.38M	56.49M	37.88M	46.68M	49.31M
Income Tax Expense	n/a	13K	5K	4K	3K	2K	-701K	-34K
Shares Outstanding (Basic)	14.26B	7.39M	5.99M	4.26M	3.96M	2.92M	2.34M	2.27M
Shares Outstanding (Diluted)	14.26B	7.41M	5.99M	4.26M	3.96M	2.92M	2.34M	2.27M
EPS (Basic)	-0.00	5.73	-5.86	-9.47	-13.45	-16.14	-21.97	-19.05
EPS (Diluted)	-0.00	5.72	-5.86	-9.47	-13.45	-16.14	-21.97	-19.05
EBITDA	-16.89M	-30.18M	-30.83M	-37.07M	-52.04M	-34.59M	-36.43M	-28.99M
EBIT	-10.42M	65.2M	-32.8M	-37.07M	-52.04M	-34.59M	-38.17M	-31.04M
Depreciation & Amortization	311K	6.45M	5.13M	3.89M	2.17M	575K	1.74M	2.05M